CA 125 test

Cancer antigen 125 (CA125) is a membrane protein found on the surface of certain cell types including ovaries, fallopian tubes, endometrium, and peritoneum. CA125 is used as biomarker for tumor detection, which means its elevated level in the blood could be an indication of cancer.

Purpose CA125 test

The CA125 test is used for various purposes, including:

The CA125 test is used to for ovarian cancer screening in women who are at high risk for the disease. However, it is not a reliable screening test for all women, as is level can be increased in other conditions, such as endometriosis or pelvic inflammatory disease.

The test is used to diagnose other types of cancer, such as endometrial cancer, fallopian tube cancer, and lung cancer.

The test is also used to monitor patients who have already been diagnosed with ovarian cancer. Elevated levels of CA125 may indicate the progression or spreading of cancer.

Role in Pathogenesis:

CA125 protein is involved in cell adhesion and movement, both of which are important for cancer growth and metastasis.

This protein suppresses the bodies’ defense mechanisms against tumors, thereby making it harder for us to fight off the disease.

It also induces the formation of new blood vessels, which are necessary for tumor growth.

The blood level of CA125 is correlated with the size and extent of the tumor.

To check if the treatment is effective, CA125 monitoring can be used. A drop in CA125 levels may suggest effective treatment, while an increase in its level may indicate the progression of cancer.

Procedure

The CA125 test is a simple blood test. A small sample of blood is drawn from a vein in your arm and sent to a laboratory for analysis.

Understanding CA-125 Test Results

Healthcare provider will review CA-125 test results along with other details about the condition. One can discuss the results interpretation, diagnosis, treatment plan and further evaluation if needed.

Expectation of results might indicate:

If one is undergoing treatment for ovarian cancer: A decrease in CA-125 levels over several tests usually suggests that the treatment is effective. Conversely, if your levels remain the same or increase, it might indicate that the treatment isn't working.

If one has completed treatment for ovarian cancer: An increase in CA-125 levels over time may suggest that the cancer is returning.

If you are at high risk for ovarian cancer or have a suspicious pelvic mass: High CA-125 levels could indicate cancer, and the healthcare provider suggests additional tests to confirm the diagnosis.

Other conditions with high CA-125 levels: Elevated CA-125 levels do not always mean cancer. Conditions such as endometriosis, pelvic inflammatory disease (PID), uterine fibroids, liver disease, pregnancy, and certain times during your menstrual cycle can also cause high CA-125 levels.

Normal CA-125 levels: A normal result does not rule out ovarian cancer, as CA-125 levels can be low in the early stages of cancer or not elevated in all individuals with ovarian cancer.

Clinical Significance of CA125:

CA125 is critical in preoperative assessment of patients with an adnexal mass and suspected ovarian malignancy. Below are some of the findings as per research analysis.

• About 80% of patients with ovarian epithelial cancer have high levels of CA125. Monitoring CA125 during treatment helps evaluate the progression of the disease.
• The test is valuable in postmenopausal women compared to premenopausal women. An increase in CA125 above 35U/mL is used for further assessment in postmenopausal women. 
• A few patients with CA125 levels >35 U/mL often show disease recurrence on second-look surgery. CA125 levels <35 U/mL indicate minimal residual disease in about half of the patients.
• In 75% of patients in complete remission, CA125 elevation precedes tumor recurrence.
• The FDA approved serial measurement of CA125 for monitoring therapeutic response.
• CA125 is not feasible for screening ovarian cancer. Multimodal screening with transvaginal ultrasound does not improve mortality.

Limitations of the CA125 test:

• The CA125 test can sometimes be elevated in people who do not have cancer. This is called a false positive.
• The CA125 test can sometimes be normal in people who have cancer. This is called a false negative.
• The CA125 test is not a definitive test for cancer. It must be used in conjunction with other tests and clinical findings to make a diagnosis.

Evaluation and Management of Suspected Ovarian Malignancy in addition to CA-125 testing

• Current standards recommend the use of formal risk assessment tests in premenstrual women, such as the Risk of Malignancy Index or the Risk of Ovarian Malignancy Algorithm. These tools are designed to study the probability of ovarian cancer based on different clinical and lab parameters. The RMI combines factors like menopausal status, ultrasound results and CA-125 levels whereas ROMA involves menopause plus CA-125 and HE4 levels. These evaluations help people in charge determine if more tests should be performed, including consultation with a gynecological oncologist.
• In combination with these tools an all-rounded clinical review which entails comprehensive past medical history taking alongside physical examination is essential. Imaging is done in identifying ovarian masses primarily through transvaginal ultrasound. Factors like size, morphology, presence of solid areas or septations are importantly considered during assessment.
• Oncological suspicion should be referred to a specialized center with experts in the management of heart cancer. Coordinated care and accessibility to advanced medical treatments can be used by a multidisciplinary team to improve patient prognosis.
• The surgical approach may vary depending on individual patient’s risk profile and general health in cases where operation is indicated. As opposed to open surgery, minimally invasive operations like laparoscopy are preferred because they take shorter recovery time and have fewer complications. Nonetheless, the choice of surgical method should be individualized about the patient’s circumstances so that it doesn’t compromise cancer principles.

General features for CA-125 test

• The CA125 test is not recommended for routine screening in women especially with high risk for ovarian cancer.
• The test is also not a replacement or alternative to regular pelvic exams and other screening tests.
• Compared to premenopausal women, the test results are accurate for postmenopausal women. 

Conclusion:

The CA125 test is an important diagnostic tool for diagnosing and monitoring ovarian cancer. However, the test is often used in conjunction with other laboratory measurements to understand the accurate pathology and diagnose the condition. 

Popular Searches :

Hospitals: Cancer Hospital in Delhi | Best Heart Hospital in Delhi |  Hospital in Amritsar | Hospital in Ludhiana | Hospitals in Mohali | Hospital in Faridabad | Hospitals in Gurgaon | Best Hospital in Jaipur | Hospitals in Greater Noida | Hospitals in Noida | Best Kidney Hospital in Kolkata | Best Hospital in Kolkata | Hospitals in Rajajinagar Bangalore | Hospitals in Richmond Road Bangalore | Hospitals in Nagarbhavi Bangalore | Hospital in Kalyan West | Hospitals in Mulund | Best Hospital in India | | Cardiology Hospital in India | Best Cancer Hospital in India | Best Cardiology Hospital in India | Best Oncology Hospital In India | Best Cancer Hospital in Delhi | Best Liver Transplant Hospital in India

Doctors: Dr. Rana Patir | Dr. Rajesh Benny | Dr. Rahul Bhargava | Dr. Jayant Arora | Dr. Anoop Misra | Dr. Manu Tiwari | Dr. Praveer Agarwal | Dr. Arup Ratan Dutta | Dr. Meenakshi Ahuja | Dr. Anoop Jhurani | Dr. Shivaji Basu | Dr. Subhash Jangid | Dr. Atul Mathur | Dr. Gurinder Bedi | Dr. Monika Wadhawan | Dr. Debasis Datta | Dr. Shrinivas Narayan | Dr. Praveen Gupta | Dr. Nitin Jha | Dr. Raghu Nagaraj | Dr. Ashok Seth | Dr. Sandeep Vaishya | Dr. Atul Mishra | Dr. Z S Meharwal | Dr. Ajay Bhalla | Dr. Atul Kumar Mittal | Dr. Arvind Kumar Khurana | Dr. Narayan Hulse | Dr. Samir Parikh | Dr. Amit Javed | Dr. Narayan Banerjee | Dr. Bimlesh Dhar Pandey | Dr. Arghya Chattopadhyay | Dr. G.R. Vijay Kumar | Dr Ashok Gupta | Dr. Gourdas Choudhuri | Dr. Sushrut Singh | Dr. N.C. Krishnamani | Dr. Atampreet Singh | Dr. Vivek Jawali | Dr. Sanjeev Gulati | Dr. Amite Pankaj Aggarwal | Dr. Ajay Kaul | Dr. Sunita Varma | Dr. Manoj Kumar Goel | Dr. R Muralidharan | Dr. Sushmita Roychowdhury | Dr. T.S. MAHANT | Dr. UDIPTA RAY | Dr. Aparna Jaswal | Dr. Ravul Jindal | Dr. Savyasachi Saxena | Dr. Ajay Kumar Kriplani | Dr. Nitesh Rohatgi | Dr. Anupam Jindal 

Specialties: Heart Lung Transplant | Orthopedic | Cardiology Interventional | Obstetrics & Gynaecology | Onco Radiation | Neurosurgery |  Interventional Cardiology | Gastroenterologist in Jaipur | Neuro Physician | Gynecologist in Kolkata | Best Neurologist in India | Liver Transfer | Best Cardiologist in Delhi